Dr. Pedro A Rodriguez

D.D.S. | Dentist



  
  680 Youngstown-warren Rd, Niles
  Ohio, 44446

  330-989-6550    330-989-6551 Maps & Directions
Dr. Pedro A Rodriguez is a Niles, Ohio based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 680 Youngstown-warren Rd, Niles. Patients can reach him at 330-989-6550.
Dr. Pedro A Rodriguez is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Pedro A Rodriguez speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Pedro A Rodriguez
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:680 Youngstown-warren Rd, Niles,
Ohio, 44446
Phone:330-989-6550
Fax:330-989-6551
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 0042436081
Enrollment ID: I20140728000982
NPI Number: 1790930725
NPI Enumeration Date: 18 Nov, 2008
NPI Last Update On: 23 Oct, 2012

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 680 Youngstown-warren Rd,
Niles, Ohio
Zip: 44446
Phone Number: 330-989-6550
Fax Number: 330-989-6551
Patients can reach Dr. Pedro A Rodriguez at 680 Youngstown-warren Rd, Niles, Ohio or can call to book an appointment on 330-989-6550. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: